Kura Oncology (KURA) EBT (2010 - 2026)
Kura Oncology's (KURA) quarterly EBT came in at -$73.3 million in Q1 2026, down 28.18% year-on-year from -$102.1 million in Q1 2025, and up 9.39% on a QoQ basis from -$80.9 million in Q4 2025.
Kura Oncology (KURA) EBT (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 8 years of EBT data on file, last reported at -$73.3 million in Q1 2026.
- On a quarterly basis, EBT fell 28.18% year-over-year to -$73.3 million in Q1 2026; TTM through Mar 2026 was -$294.5 million, a 3735.52% decrease from a year earlier, with the FY2025 full-year figure at -$278.4 million, changed N/A from the prior year.
- EBT for Q1 2026 stood at -$73.3 million, up from -$80.9 million in the prior quarter.
- Over the last five years, EBT for KURA reached as high as $154.8 million in Q4 2024 and fell as low as -$80.9 million in Q4 2025.
- Historically, EBT has averaged -$39.1 million across 3 years, with a median of -$57.2 million in 2025.
- On a YoY basis, EBT climbed as much as 15.5% in 2025 and fell as far as 152.29% in 2025.
- Year by year, EBT stood at $154.8 million in 2024, then slumped by 152.29% to -$80.9 million in 2025, then gained by 9.39% to -$73.3 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$73.3 million in Q1 2026, -$80.9 million in Q4 2025, and -$74.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Kura Oncology | 928.19 Mn | 928.19 Mn | 18.00 Mn | -73.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.33 Mn |
| Dec 31, 2025 | -80.93 Mn |
| Sep 30, 2025 | -74.12 Mn |
| Jun 30, 2025 | -66.12 Mn |
| Mar 31, 2025 | -57.20 Mn |
| Dec 31, 2024 | 154.77 Mn |
| Sep 30, 2024 | -54.40 Mn |
| Jun 30, 2024 | -50.84 Mn |
| Mar 31, 2024 | -49.53 Mn |
| Dec 31, 2014 | -46,762.00 |
| Sep 30, 2014 | -6,428.00 |
| Jun 30, 2014 | -6,887.00 |
| Mar 31, 2014 | -5,766.00 |
| Dec 31, 2013 | -9,750.00 |
| Sep 30, 2013 | -6,139.00 |
| Jun 30, 2013 | -6,749.00 |
| Mar 31, 2013 | -5,973.00 |
| Dec 31, 2012 | -9,662.00 |
| Sep 30, 2012 | -6,013.00 |
| Jun 30, 2012 | -6,268.00 |